Karakteristik Pasien dan Penggunaan Obat Pada Pasien Covid-19 Derajat Sedang-Berat di RSUD Karangasem

Ni Made Maharianingsih, I Ketut Sudirta, Ni Putu Aryati Suryaningsih

Abstract


 The development of cases of COVID-19 (coronavirus disease 2019) in the province Bali to increase until it ranks 10 th in Indonesia. This study aims to determine the characteristics of patients and the description of drug use for COVID-19 patients at Karangasem Hospital Bali for the period April 2020-Aril 2021. This study used a descriptive observational method with a cross-sectional design through a retrospective data search. The research was carried out in May 2021, which was located at the RSUD Karangasem. The population of this study were all moderate to severe COVID-19 inpatients at RSUD Karangasem  in the period April 2020 - April 2021. The number of respondents as a sample was 200 patients with purposive sampling technique. The data collected is in the form of secondary data, which comes from medical records of COVID-19 patients at Karangasem Hospital. The results of the study showed that the most COVID-19 patients in Karangasem RSUD were from adults as many as 109 people (54.5%). Clinical symptoms experienced by all patients were fever with body temperature 38°C for more than 3 days and headache (100%). Patients who had comorbid as many as 196 people (98%) with pneumonia being the highest comorbid as many as 102 people (51%). The length of hospitalization for patients is generally 0-7 days by 69% (138 people). The highest patient status experienced moderate degree of symptoms by 89% (178 people) and severe 11% (22 people). The most drugs given to patients was vitamin C intravenously by 71% (142 people), while antiviral drugs in the form of oseltamivir (tamiflu) became the least by 1% (2 people). The conclusion of the study is that the characteristics of moderate-to-severe COVID-19 patients are dominated by male adult patients, have comorbidities (98%), clinical symptoms experienced by all patients are fever for more than 3 days and headache, with hospitalization for more than 3 days. The type of drug that is most often used is for antipyretic analgesics is paracetamol, the type of antibiotic is azithromycin, the type of antiviral is favipiravir, the type of corticosteroid is dexamethasone.

 Keywords: COVID-19, treatment, characteristics


Keywords


COVID-19, treatment, characteristics

Full Text:

PDF

References


Referensi

Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020;71(15):778–85.

Update Penanggulangan Covid-19, Kamis, 8 Juli 2021.

Şimşek Yavuz S, Ünal S. Antiviral treatment of covid-19. Turkish J Med Sci. 2020;50(SI-1):611–9.

Setiadi AP, Wibowo YI, Halim S V., Brata C, Presley B, Setiawan E. Tata Laksana Terapi Pasien dengan COVID-19: Sebuah Kajian Naratif. Indones J Clin Pharm. 2020;9(1):70.

Shyr ZA, Gorshkov K, Chen CZ, Zheng W. Drug discovery strategies for sars-cov-2. J Pharmacol Exp Ther. 2020;375(1):127–38.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.

Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(January):497–506.

Donsu YC, Hasmono D. Tinjauan Azitromisin Pada Penyakit Virus Korona 2019 (COVID-19). Pharmacon J Farm Indones. 2020;17(2):133–47.

PDPI, PERKI, PAPDI, PERDATIN, IDAI. Pedoman tatalaksana COVID-19 Edisi 3 Desember 2020 [Internet]. Pedoman Tatalaksana COVID-19. 2020. 36–37 p. Available from: https://www.papdi.or.id/download/983-pedoman-tatalaksana-covid-19-edisi-3-desember-2020

KANGDRA .W.Y. Karakteristik Klinis Dan Faktor Komorbidpada Pasien Dalam Pengawasan (Pdp) Coronavirus Disease 2019(Covid-19)Di Rs Mitra Medika Amplas. Vol. 2019. 2021. i–155.

Ramadani Latifah, Hidayat Nopian FD. Gambaran Penggunaan Analgetik Pada Pasien Rawatan Intensif Di Rsud Arifin Achmad Provinsi Riau Periode. J Chem Inf Model. 2019;1(1):1–13.

Jayanti D. Perilaku Masyarakat Dalam Melakukan SWAMEDIKASI Untuk Penyakit Batuk Di Dusun Krodan, Maguwoharjo, Sleman, Daerah Istimewa Yogyakarta Tahun 2012. Skripsi Fak Farm Univ Sanata Dharma Yogyakarta. 2012;53(9):202.

RI KK. Pedoman Kesiapsiagaan Menghadapi Infeksi COVID-19. Kementrian Kesehat Republik Indones [Internet]. 2020;75. Available from: https://www.kemkes.go.id/resources/download/info-terkini/Coronavirus/DOKUMEN_RESMI_Pedoman_Kesiapsiagaan_nCoV_Indonesia_28 Jan 2020.pdf

Ardyati S, Kurniawan NU, Darmawan E. Steroids Effect as Adjuvant Therapy toward Length of Stay and Clinical Symptoms in Pediatric with Pneumonia. Indones J Clin Pharm. 2017;6(3):181–9.

Hasan M, Levani Y, Laitupa AA, Triastuti N. Pemberian Terapi Vitamin C pada COVID-19. J Pandu Husada. 2021;2(2):74.




DOI: https://doi.org/10.37311/ijpe.v2i2.13958

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Indonesian Journal of Pharmaceutical Education